Pricing
Login
Home
Charts
Search
Watchlist
Products

Coral Laboratories Ltd

CORALAB
₹680.10+2.46%20 Nov 2026
Reports
Pharma Formulations

Coral Laboratories Ltd

CORALAB
₹680.10
+2.46%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹243Cr
Close
Close Price
₹680.10
Industry
Industry
Pharma Formulations
PE
Price To Earnings
11.11
PS
Price To Sales
2.13
Revenue
Revenue
₹114Cr
Rev Gr TTM
Revenue Growth TTM
28.17%
PAT Gr TTM
PAT Growth TTM
26.11%

Quarterly Results

Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
182932322328191922263036
Growth YoY
Revenue Growth YoY%
-26.9152.5133.739.227.2-2.6-40.6-41.0-6.2-5.957.491.1
Expenses
ExpensesCr
162321261725171420202427
Operating Profit
Operating ProfitCr
2611763252659
OPM
OPM%
11.621.633.920.227.49.511.625.98.823.418.525.6
Other Income
Other IncomeCr
122332232322
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
010111001111
PBT
PBTCr
38129844748711
Tax
TaxCr
123221121322
PAT
PATCr
269663363558
Growth YoY
PAT Growth YoY%
151.2750.6378.36.3184.3-51.1-70.9-8.8-54.784.5110.545.9
NPM
NPM%
11.920.027.819.826.710.113.630.612.919.718.223.3
EPS
EPS₹
6.016.224.617.917.27.97.216.37.814.615.123.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
182932322328191922263036
Growth YoY
Revenue Growth YoY%
-26.9152.5133.739.227.2-2.6-40.6-41.0-6.2-5.957.491.1
Expenses
ExpensesCr
162321261725171420202427
Operating Profit
Operating ProfitCr
2611763252659
OPM
OPM%
11.621.633.920.227.49.511.625.98.823.418.525.6
Other Income
Other IncomeCr
122332232322
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
010111001111
PBT
PBTCr
38129844748711
Tax
TaxCr
123221121322
PAT
PATCr
269663363558
Growth YoY
PAT Growth YoY%
151.2750.6378.36.3184.3-51.1-70.9-8.8-54.784.5110.545.9
NPM
NPM%
11.920.027.819.826.710.113.630.612.919.718.223.3
EPS
EPS₹
6.016.224.617.917.27.97.216.37.814.615.123.8

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
77959291719776788411586114
Growth
Revenue Growth%
29.624.0-3.1-1.5-22.536.8-21.73.37.137.5-25.328.2
Expenses
ExpensesCr
617277796581677467897191
Operating Profit
Operating ProfitCr
162315125168416261523
OPM
OPM%
21.224.216.413.57.516.410.94.919.422.817.720.1
Other Income
Other IncomeCr
33456467681010
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
222222222223
PBT
PBTCr
1725181691812821322330
Tax
TaxCr
586524325878
PAT
PATCr
121612107149616241622
Growth
PAT Growth%
29.531.4-23.6-17.9-30.290.1-33.3-28.8145.053.0-32.226.1
NPM
NPM%
16.117.113.511.210.114.012.08.318.921.019.119.2
EPS
EPS₹
34.745.634.828.620.037.925.318.044.267.645.961.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
77959291719776788411586114
Growth
Revenue Growth%
29.624.0-3.1-1.5-22.536.8-21.73.37.137.5-25.328.2
Expenses
ExpensesCr
617277796581677467897191
Operating Profit
Operating ProfitCr
162315125168416261523
OPM
OPM%
21.224.216.413.57.516.410.94.919.422.817.720.1
Other Income
Other IncomeCr
33456467681010
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
222222222223
PBT
PBTCr
1725181691812821322330
Tax
TaxCr
586524325878
PAT
PATCr
121612107149616241622
Growth
PAT Growth%
29.531.4-23.6-17.9-30.290.1-33.3-28.8145.053.0-32.226.1
NPM
NPM%
16.117.113.511.210.114.012.08.318.921.019.119.2
EPS
EPS₹
34.745.634.828.620.037.925.318.044.267.645.961.2
Sales CAGR
1 Year-25%
3 Years3%
5 Years-2%
TTM28%
EBITDA CAGR
1 Year-42%
3 Years59%
5 Years-1%
TTM42%
PAT CAGR
1 Year-32%
3 Years36%
5 Years4%
TTM26%
Avg. ROCE
1 Year11%
3 Years13%
5 Years10%
TTM12%
CFO / EBITDA
1 Year103%
3 Years15%
5 Years40%
TTM-

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
444444444444
Reserves
ReservesCr
67106113110112133152151174198206223
Current Liabilities
Current LiabilitiesCr
181920182528261225252745
Non Current Liabilities
Non Current LiabilitiesCr
134443883344
Total Liabilities
Total LiabilitiesCr
89131140136144168190174206229241276
Current Assets
Current AssetsCr
6574728496129131124154177177209
Non Current Assets
Non Current AssetsCr
255868524839595152536467
Total Assets
Total AssetsCr
89131140136144168190174206229241276
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
444444444444
Reserves
ReservesCr
67106113110112133152151174198206223
Current Liabilities
Current LiabilitiesCr
181920182528261225252745
Non Current Liabilities
Non Current LiabilitiesCr
134443883344
Total Liabilities
Total LiabilitiesCr
89131140136144168190174206229241276
Current Assets
Current AssetsCr
6574728496129131124154177177209
Non Current Assets
Non Current AssetsCr
255868524839595152536467
Total Assets
Total AssetsCr
89131140136144168190174206229241276

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
51113-1-41613-5-116
Investing Cash Flow
Investing Cash FlowCr
-3-10-133-20-6-310-18
Financing Cash Flow
Financing Cash FlowCr
00-3-1400-6030
Net Cash Flow
Net Cash FlowCr
21-21-2104-41-2
Free Cash Flow
Free Cash FlowCr
499-4-50111-6-2
CFO To PAT
CFO To PAT%
40.866.1108.2-8.6-54.26.967.3196.5-34.6-5.195.3
CFO To EBITDA
CFO To EBITDA%
31.046.688.7-7.2-73.05.974.1332.3-33.6-4.7102.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
51113-1-41613-5-116
Investing Cash Flow
Investing Cash FlowCr
-3-10-133-20-6-310-18
Financing Cash Flow
Financing Cash FlowCr
00-3-1400-6030
Net Cash Flow
Net Cash FlowCr
21-21-2104-41-2
Free Cash Flow
Free Cash FlowCr
499-4-50111-6-2
CFO To PAT
CFO To PAT%
40.866.1108.2-8.6-54.26.967.3196.5-34.6-5.195.3
CFO To EBITDA
CFO To EBITDA%
31.046.688.7-7.2-73.05.974.1332.3-33.6-4.7102.7

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
161258212113351159182133250132243
Price To Earnings
Price To Earnings
13.315.817.111.14.98.510.112.78.410.48.111.1
Price To Sales
Price To Sales
2.12.72.31.20.51.21.21.11.62.21.52.1
Price To Book
Price To Book
2.32.41.81.00.30.80.60.50.81.30.61.1
EV To EBITDA
EV To EBITDA
9.410.713.47.52.15.57.310.84.46.64.27.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
36.238.635.634.334.140.038.831.647.147.550.150.1
OPM
OPM%
21.224.216.413.57.516.410.94.919.422.817.720.1
NPM
NPM%
16.117.113.511.210.114.012.08.318.921.019.119.2
ROCE
ROCE%
24.822.115.313.57.512.47.45.511.715.910.912.5
ROE
ROE%
17.714.910.79.06.29.95.84.28.912.07.89.7
ROA
ROA%
13.912.48.97.54.98.14.83.77.710.56.87.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
161258212113351159182133250132243
Price To Earnings
Price To Earnings
13.315.817.111.14.98.510.112.78.410.48.111.1
Price To Sales
Price To Sales
2.12.72.31.20.51.21.21.11.62.21.52.1
Price To Book
Price To Book
2.32.41.81.00.30.80.60.50.81.30.61.1
EV To EBITDA
EV To EBITDA
9.410.713.47.52.15.57.310.84.46.64.27.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
36.238.635.634.334.140.038.831.647.147.550.150.1
OPM
OPM%
21.224.216.413.57.516.410.94.919.422.817.720.1
NPM
NPM%
16.117.113.511.210.114.012.08.318.921.019.119.2
ROCE
ROCE%
24.822.115.313.57.512.47.45.511.715.910.912.5
ROE
ROE%
17.714.910.79.06.29.95.84.28.912.07.89.7
ROA
ROA%
13.912.48.97.54.98.14.83.77.710.56.87.9
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr435402338243237233233
Close PriceClose₹762.60285.9093.41680.10150.0038.16404.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE15.1432.1611.1112.4020.45
Price To SalesPS1.151.912.322.131.065.752.29
RevenueRevenueCr37821014511422441101
Revenue Growth TTMRev Gr TTM%19.7%27.5%6.1%28.2%26.7%-8.4%41.8%
PAT Growth TTMPAT Gr TTM%290.6%41.9%-294.4%26.1%43.3%-238.4%16.6%
Market CapitalizationMkt CapCr435402338243237233233
Close PriceClose₹762.60285.9093.41680.10150.0038.16404.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE15.1432.1611.1112.4020.45
Price To SalesPS1.151.912.322.131.065.752.29
RevenueRevenueCr37821014511422441101
Revenue Growth TTMRev Gr TTM%19.7%27.5%6.1%28.2%26.7%-8.4%41.8%
PAT Growth TTMPAT Gr TTM%290.6%41.9%-294.4%26.1%43.3%-238.4%16.6%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Mar 26
Result
PPT
Transcript
Summary
Dec 25
Result
PPT
Transcript
Summary
Sep 25
Result
PPT
Transcript
Summary
Jun 25
Result
PPT
Transcript
Summary
Mar 25
Result
PPT
Transcript
Summary
Dec 24
Result
PPT
Transcript
Summary
Sep 24
Result
PPT
Transcript
Summary
Jun 24
Result
PPT
Transcript
Summary
Mar 24
Result
PPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Sep 23
Result
PPT
Transcript
Summary
Jun 23
Result
PPT
Transcript
Summary
Mar 23
Result
PPT
Transcript
Summary
Dec 22
Result
PPT
Transcript
Summary
Sep 22
Result
PPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews